Form 4 for CAC CAMDEN NATIONAL CORP

Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0000750686-25-000008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-01-06	2025-01-02	CAC	Haynes Larry K	Dir	A - Grant	$13.70	+512	512	New	+$7,014

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-01-02	A	A	166	$42.25	166	D	—	—	(F1) Received in exchange for 200 shares of Northway Financial, Inc. ("Northway") common stock in connection with the merger of Northway with and into Camden National Corporation ("Camden") (the "Merger"), effective January 2, 2025 (the "Effective Time"). Pursuant to the terms of the Agreement and Plan of Merger, dated September 9, 2024, between Camden and Northway, as of the Effective Time, each issued and outstanding share of Northway common stock converted into the right to receive 0.83 shares of Camden common stock.
2	Common	Common Stock	2025-01-02	A	A	346	$0.00	512	D	—	—	(F2) Shares granted under the 2024 Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan; therefore, price is N/A. These shares vested immediately on the date of grant.